Terms: = Uterine cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin AND Treatment
26 results:
1. The Effect of a Myomectomy on Myoma-related Symptoms and Quality of Life: A Retrospective Cohort Study.
Don EE; Mijatovic V; van Eekelen R; Hehenkamp WJK; Huirne JAF
J Minim Invasive Gynecol; 2023 Nov; 30(11):897-904. PubMed ID: 37453499
[TBL] [Abstract] [Full Text] [Related]
2. uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
Natsume T; Yoshida H; Nishikawa T; Kikkawa N; Naka T; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2023 Aug; 31(5):778-784. PubMed ID: 36310451
[TBL] [Abstract] [Full Text] [Related]
3. The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma.
Kang CW; Hannan KM; Blackburn AC; Loh AHP; Hong KC; Yuan GJ; Hein N; Drygin D; Hannan RD; Coupland LA
Invest New Drugs; 2022 Jun; 40(3):529-536. PubMed ID: 35201535
[TBL] [Abstract] [Full Text] [Related]
4. Tuberous sclerosis complex misdiagnosed as multiple metastases in a cervical cancer patient: case report and literature review.
Ye T; Feng L; Peng M; Yuan S; Chen Y; Liu X; Chen J
Ann Palliat Med; 2021 Oct; 10(10):11232-11238. PubMed ID: 34763482
[TBL] [Abstract] [Full Text] [Related]
5. Phase II Clinical Trial of Everolimus in a Pan-cancer Cohort of Patients with mTOR Pathway Alterations.
Adib E; Klonowska K; Giannikou K; Do KT; Pruitt-Thompson S; Bhushan K; Milstein MI; Hedglin J; Kargus KE; Sholl LM; Tsuji J; Hyman DM; Sisk A; Shapiro GI; Vargas HA; Harding JJ; Voss MH; Iyer G; Kwiatkowski DJ
Clin Cancer Res; 2021 Jul; 27(14):3845-3853. PubMed ID: 33727259
[TBL] [Abstract] [Full Text] [Related]
6. Neutrophil elastase from myeloid cells promotes tsc2-null tumor growth.
Taya M; Garcia-Hernandez ML; Rangel-Moreno J; Minor B; Gibbons E; Hammes SR
Endocr Relat Cancer; 2020 Apr; 27(4):261-274. PubMed ID: 32045362
[TBL] [Abstract] [Full Text] [Related]
7. Familial Kidney cancer: Implications of New Syndromes and Molecular Insights.
Carlo MI; Hakimi AA; Stewart GD; Bratslavsky G; Brugarolas J; Chen YB; Linehan WM; Maher ER; Merino MJ; Offit K; Reuter VE; Shuch B; Coleman JA
Eur Urol; 2019 Dec; 76(6):754-764. PubMed ID: 31326218
[TBL] [Abstract] [Full Text] [Related]
8. Five cases of uterine perivascular epithelioid cell tumors (PEComas) and review of literature.
Shan W; Shi Y; Zhu Q; Yang B; Xie L; Li B; Ning C; Lv Q; Cheng Y; Xie B; Bai M; Xu Y; Chen X; Luo X
Arch Gynecol Obstet; 2019 Jan; 299(1):185-190. PubMed ID: 30317387
[TBL] [Abstract] [Full Text] [Related]
9. treatment of Advanced Malignant uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature.
Starbuck KD; Drake RD; Budd GT; Rose PG
Anticancer Res; 2016 Nov; 36(11):6161-6164. PubMed ID: 27793946
[TBL] [Abstract] [Full Text] [Related]
10. Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2.
Goldberg AA; Joung KB; Mansuri A; Kang Y; Echavarria R; Nikolajev L; Sun Y; Yu JJ; Laporte SA; Schwertani A; Kristof AS
Oncotarget; 2016 Sep; 7(38):61152-61165. PubMed ID: 27458154
[TBL] [Abstract] [Full Text] [Related]
11. Minireview: Lymphangioleiomyomatosis (lam): The "Other" Steroid-Sensitive cancer.
Prizant H; Hammes SR
Endocrinology; 2016 Sep; 157(9):3374-83. PubMed ID: 27409646
[TBL] [Abstract] [Full Text] [Related]
12. Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model.
Prizant H; Taya M; Lerman I; Light A; Sen A; Mitra S; Foster TH; Hammes SR
Endocr Relat Cancer; 2016 Apr; 23(4):265-80. PubMed ID: 26880751
[TBL] [Abstract] [Full Text] [Related]
13. Brain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated Tumorigenesis.
Hu Z; Wang Y; Huang F; Chen R; Li C; Wang F; Goto J; Kwiatkowski DJ; Wdzieczak-Bakala J; Tu P; Liu J; Zha X; Zhang H
J Biol Chem; 2015 Oct; 290(42):25756-65. PubMed ID: 26296882
[TBL] [Abstract] [Full Text] [Related]
14. Effects of combining rapamycin and resveratrol on apoptosis and growth of tsc2-deficient xenograft tumors.
Alayev A; Salamon RS; Sun Y; Schwartz NS; Li C; Yu JJ; Holz MK
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):637-46. PubMed ID: 25844891
[TBL] [Abstract] [Full Text] [Related]
15. Progesterone and estradiol synergistically promote the lung metastasis of tuberin-deficient cells in a preclinical model of lymphangioleiomyomatosis.
Sun Y; Zhang E; Lao T; Pereira AM; Li C; Xiong L; Morrison T; Haley KJ; Zhou X; Yu JJ
Horm Cancer; 2014 Oct; 5(5):284-98. PubMed ID: 25069840
[TBL] [Abstract] [Full Text] [Related]
16. [Nephrotic syndrome in a woman with tuberous sclerosis].
Sauter M; Berger F; Fischereder M
Dtsch Med Wochenschr; 2014 May; 139(20):1046-50. PubMed ID: 24801299
[TBL] [Abstract] [Full Text] [Related]
17. mTORC1 enhancement of STIM1-mediated store-operated Ca2+ entry constrains tuberous sclerosis complex-related tumor development.
Peng H; Liu J; Sun Q; Chen R; Wang Y; Duan J; Li C; Li B; Jing Y; Chen X; Mao Q; Xu KF; Walker CL; Li J; Wang J; Zhang H
Oncogene; 2013 Sep; 32(39):4702-11. PubMed ID: 23108404
[TBL] [Abstract] [Full Text] [Related]
18. Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1.
Tanwar PS; Kaneko-Tarui T; Zhang L; Tanaka Y; Crum CP; Teixeira JM
PLoS Genet; 2012; 8(8):e1002906. PubMed ID: 22916036
[TBL] [Abstract] [Full Text] [Related]
19. Anticancer property of Bryophyllum pinnata (lam.) Oken. leaf on human cervical cancer cells.
Mahata S; Maru S; Shukla S; Pandey A; Mugesh G; Das BC; Bharti AC
BMC Complement Altern Med; 2012 Mar; 12():15. PubMed ID: 22405256
[TBL] [Abstract] [Full Text] [Related]
20. Favorable response to antigonadal therapy for a benign metastasizing leiomyoma.
Taveira-DaSilva AM; Alford CE; Levens ED; Kotz HL; Moss J
Obstet Gynecol; 2012 Feb; 119(2 Pt 2):438-442. PubMed ID: 22270431
[TBL] [Abstract] [Full Text] [Related]
[Next]